The CNS wishes to publish this opinion today, at a time when a committee of experts recommended the FDA to approve a supplemental New Drug Application for an antiretroviral treatment to be used for PrEP.

You will find on this website :
- the complete Opinion
- the Summary of the Opinion in pdf format
- the Press release

image 478